Enanta Pharmaceuticals (ENTA)
(Delayed Data from NSDQ)
$11.28 USD
-0.02 (-0.18%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $11.28 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/18/24 |
---|---|
Current Quarter | -1.16 |
EPS Last Quarter | -1.07 |
Last EPS Surprise | 28.19% |
ABR | 2.43 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -5.30 |
Next Year | -5.02 |
EPS (TTM) | -5.45 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 18.73M | 17.19M | 71.87M | 77.82M |
# of Estimates | 5 | 2 | 5 | 5 |
High Estimate | 20.00M | 19.00M | 73.60M | 111.94M |
Low Estimate | 17.89M | 15.37M | 70.92M | 66.46M |
Year ago Sales | 18.93M | 18.00M | 79.20M | 71.87M |
Year over Year Growth Est. | -1.05% | -4.53% | -9.26% | 8.28% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.16 | -1.24 | -5.30 | -5.02 |
# of Estimates | 4 | 2 | 4 | 4 |
Most Recent Consensus | -1.50 | -1.16 | -5.62 | -5.87 |
High Estimate | -0.70 | -1.16 | -4.83 | -4.55 |
Low Estimate | -1.50 | -1.31 | -5.62 | -5.87 |
Year ago EPS | -1.33 | -1.58 | -6.38 | -5.30 |
Year over Year Growth Est. | 12.78% | 21.52% | 16.93% | 5.24% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 0 | 4 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 0 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Current | -1.16 | -1.24 | -5.30 | -5.02 |
7 Days Ago | -1.16 | -1.24 | -5.30 | -5.02 |
30 Days Ago | -1.22 | -1.24 | -5.33 | -4.83 |
60 Days Ago | -1.46 | -1.15 | -5.86 | -4.80 |
90 Days Ago | -1.46 | -1.15 | -5.86 | -4.80 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.16 | -1.24 | -5.30 | -5.02 |
Zacks Consensus Estimate | -1.16 | -1.24 | -5.30 | -5.02 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.07 | -1.47 | -1.58 | -1.33 | NA |
Estimate | -1.49 | -1.26 | -1.18 | -2.11 | NA |
Difference | 0.42 | -0.21 | -0.40 | 0.78 | 0.15 |
Surprise | 28.19% | -16.67% | -33.90% | 36.97% | 3.65% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more